Clinical trial
A Study Testing the Effect and Safety of Casopitant (GW679769) While Taking…
NCT00404274 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00404274 |
|---|---|
| Title | A Study Testing the Effect and Safety of Casopitant (GW679769) While Taking Warfarin in Healthy Human Volunteers |
| Official title | An Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Steady-State Warfarin When Co-administered With Repeat Doses of Casopitant [GW679769] in Healthy Adult Subjects. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Nausea and Vomiting, Chemotherapy-Induced |
| Intervention type | Drug |
| Interventions | Casopitant (GW679769) oral tablets, Warfarin oral tablets |
| Enrollment | 97 |
| Start date | Nov 1, 2006 |
| Primary completion | Mar 18, 2007 |
| Completion | Mar 18, 2007 |
| First posted | Nov 28, 2006 |
| Last update posted | Aug 9, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: